Research with the Johns Hopkins Division of Reproductive Endocrinology and Infertility (REI) has recently focused on perimenopause and menopause and risks for hot flashes, fertility preservation and on making advances in improving success rates for assisted reproductive technologies. Past research efforts focused on hormonal contraception, prolactin disorders and polycystic ovarian syndrome.

There was continuous NIH funding of clinical research in perimenopause and menopause from 1991 until 2016. The Johns Hopkins REI Division participated in the NIH funded Post-Menopausal-Estrogen Progestin-Intervention Trial (PEPI) in the early 1990s. This was followed by the industry sponsored Heart Estrogen/Progestin Replacement Study (HERS) and then by the NIH funded Risk Factors for Hot Flashes in Perimenopause study. Numerous publications resulted from these investigations.

Recently funding has been provided to Dr. Mindy Christianson to support her research in fertility preservation from Ferring Pharmaceutical and funding from the CDC has been provided to her to evaluate the safety of clinical vaccines.

Dr. Jairo Garcia has received pharmaceutical industry support in the past for clinical studies investigating the responses of infertility patients to different ovarian stimulation medications to improve outcomes in in vitro fertilization.